ArticleEuropean journal of medical research2026
Interpretable machine learning reveals phosphorus-to-albumin ratio as a novel predictor of mortality and acute kidney injury in critically ill pancreatitis patients: a multi-center retrospective analysis.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury (AKI), a common and severe complication of acute pancreatitis (AP), is amenable to early intervention. Phosphorus-to-albumin ratio (PAR) is a novel composite biomarker unexplored in AP largely. Data of ICU patients with AP were extracted from MIMIC-IV database and eICU-CRD, respectively. PAR's link to prognosis and AKI in AP were analyzed via Kaplan-Meier curves, Cox regression, restricted cubic splines (RCS), and logistic regression. Subgroup analysis tested interactions. Key variables were identified using least absolute shrinkage and selection operator regression. AKI prediction models were built and evaluated via seven machine learning (ML) algorithms. Shapley additive explanations (SHAP) interpreted variable contributions. Survival analysis, Cox models, and RCS collectively demonstrated PAR, as a potential risk factor, is associated with 28-day and 1-year all-cause mortality in patients with AP. Logistic regression identified PAR as a risk factor for AKI development in AP. AKI-related clinical features including PAR were indentified. Seven ML models were constructed, among which the Light Gradient Boosting Machine (LightGBM) model achieved an area under receiver operating characteristic curve (AUROC) of 0.880 (95% CI 0.825-0.935) and area under precision-recall curve (AUPRC) of 0.944 in the test set, and an AUROC of 0.837 (95% CI 0.785-0.889) and AUPRC of 0.784 in the external validation set. SHAP analysis of the LightGBM model confirmed that higher PAR levels corresponded to a higher predicted probability of AKI. PAR is associated with prognosis and AKI of patients with AP. Integrating PAR with other key clinical features, our LightGBM model provides physicians with a streamlined and efficient tool for early AKI identification in high-risk AP patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.